{"filing":{"accession_number":"0001104659-26-110971","cik":"0001661059","ticker":"NXTC","company_name":"NextCure, Inc.","form":"8-K","filing_date":"2026-09-25","report_date":"2026-09-21","primary_document":"nxtc-20260921x8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1661059/000110465926110971/nxtc-20260921x8k.htm"},"events":[{"id":35112,"run_id":32334,"accession_number":"0001104659-26-110971","anchor_item_number":"8.01","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"summary":"NextCure filed a Section 205 petition in Delaware Court of Chancery seeking validation of a 2025 reverse stock split amendment that may have been approved under an incorrect voting standard. This is a governance matter involving potential defects in a corporate act (the reverse split) and uncertainty about capitalization, which could impair the pending business combination with Avere. While not a standard governance category (not an exec change, auditor change, or shareholder vote result), it is clearly a material governance/corporate law issue affecting the validity of the company's capital structure and requiring court validation.","company_name":"NextCure, Inc.","ticker":"NXTC","filing_date":"2026-09-25","form":"8-K","submitted_at":null,"items":[{"id":39051,"accession_number":"0001104659-26-110971","item_number":"8.01","item_title":"Other Events","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"NextCure filed a Section 205 petition in Delaware Court of Chancery seeking validation of a 2025 reverse stock split amendment that may have been approved under an incorrect voting standard. This is a governance matter involving potential defects in a corporate act (the reverse split) and uncertainty about capitalization, which could impair the pending business combination with Avere. While not a standard governance category (not an exec change, auditor change, or shareholder vote result), it is clearly a material governance/corporate law issue affecting the validity of the company's capital structure and requiring court validation.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T20:15:37.175124+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":39051,"accession_number":"0001104659-26-110971","item_number":"8.01","item_title":"Other Events","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.85,"reasoning":"NextCure filed a Section 205 petition in Delaware Court of Chancery seeking validation of a 2025 reverse stock split amendment that may have been approved under an incorrect voting standard. This is a governance matter involving potential defects in a corporate act (the reverse split) and uncertainty about capitalization, which could impair the pending business combination with Avere. While not a standard governance category (not an exec change, auditor change, or shareholder vote result), it is clearly a material governance/corporate law issue affecting the validity of the company's capital structure and requiring court validation.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T20:15:37.175124+00:00","company_name":"NextCure, Inc.","ticker":"NXTC","filing_date":"2026-09-25"}]}